Amedeo Smart

Free Medical Literature Service


 

Amedeo

COVID-19

  Free Subscription

Articles published in
Zhonghua Jie He He Hu Xi Za Zhi
    March 2024
  1. GAO HB, Zhang J
    [Analysis of prognostic factors in patients with COVID-19 infection].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:296-300.
    >> Share

  2. GUO JW, Xiao Y
    [Impact of COVID-19 on the treatment of sleep medicine].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:292-296.
    >> Share

  3. YU D, Huang WQ, Zhan YZ, Xiao GH, et al
    [Diaphragmatic dysfunction post-COVID-19 infection: report of two cases].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:244-248.
    >> Share

  4. CHEN RX, Mai YL, Shen KN, Zhang T, et al
    [A case of follicular lymphoma with recurrent fever and pulmonary infiltrates].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:222-227.
    >> Share

    February 2024
  5. ZHA SS, He ZF, Guan LL, Niu JY, et al
    [Clinical research progress in non-invasive positive pressure ventilation in 2023].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:146-151.
    >> Share

  6. SHI YJ, Chen RX, Liu XN, Shao C, et al
    [Clinical analysis of COVID-19 in patients with preexisting interstitial lung abnormalities].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:126-131.
    >> Share

    December 2023
  7. WANG SY, Wang YM, Liu M, Zhao L, et al
    [Migratory pulmonary ground glass opacities caused by SARS-CoV-2 infection in a patient on B-cell depletion therapy].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:1233-1239.
    >> Share


  8. [Expert consensus on the management of interstitial lung disease during the COVID-19 epidemic].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:1204-1218.
    >> Share


  9. [Expert consensus on diagnosis and treatment of severe COVID-19 associated with pulmonary aspergillus and mucormycosis].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;47:10-23.
    >> Share

    November 2023
  10. HAN L, Sun LX, Chen YL, Shao HJ, et al
    [Clinical characteristics of a case of severe pneumonia caused by coinfection of COVID-19 and Chlamydia Psittaci].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:1118-1120.
    >> Share

    September 2023

  11. [Expert consensus on the diagnosis and management of Birt-Hogg-Dube syndrome].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:897-908.
    >> Share

    August 2023
  12. HUANG LX, Liang YD, Wang YQ, Li JT, et al
    [Hemophagocytic syndrome secondary to COVID-19: a case report and literature review].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:791-796.
    >> Share

    May 2023
  13. HUANG H
    [Comments on the systemic corticosteroid strategy for the coronavirus disease 2019 (COVID-19)].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:521-524.
    >> Share

  14. CHENG LL, Li SY, Zhong NS
    [New characteristics of COVID-19 caused by the Omicron variant in Guangzhou].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:441-443.
    >> Share

    April 2023
  15. SU Y, Cao Y, Wang RL, Dong EJ, et al
    [Progress on specific and non-specific immune effects of Bacille Calmette-Guerin].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:413-418.
    >> Share

    February 2023

  16. [Expert consensus on off-label administration of drugs in COVID-19].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:1-10.
    >> Share


  17. [Thromboprophylaxis and management of anticoagulation in hospitalized patients with COVID-19: clinical pathway and practices].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:1-16.
    >> Share

  18. TONG ZH, Jiang HY, Chen YS
    [Annual progress in pulmonary rehabilitation 2022].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:172-176.
    >> Share

  19. YANG QY, Qu JM
    [Annual update of pulmonary infectious diseases in 2022].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:168-171.
    >> Share

    January 2023

  20. [Expert consensus on the diagnosis and treatment of SARS-CoV-2-associated cough].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:E002.
    >> Share

  21. ZHA SS, He ZF, Guan LL, Niu JY, et al
    [Clinical update in non-invasive positive pressure ventilation for respiratory failure in 2022].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:77-81.
    >> Share

  22. PAN P, Xie LX
    [Clinical update in critical care of pulmonary medicine 2022].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:72-76.
    >> Share


  23. [Expert consensus on treatment of severe COVID-19 caused by Omicron variants].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:E001.
    >> Share

    December 2022
  24. LI Y, Liu SY, Zheng JP
    [Chest imaging-based artificial intelligence in the diagnosis of coronavirus disease 2019 and prospects for future research].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:1255-1260.
    >> Share

  25. SHANG FQ, Chen H, Yang X, Wu MJ, et al
    [Clinical characteristics of patients infected with 2019-nCoV Omicron variants BA.2 and BA.5 in Xi'an city, China].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:1199-1203.
    >> Share

    August 2022
  26. LONG QY, Zheng YL, Gao Z
    [Advances in SARS-CoV-2 diagnostic strategies during the later COVID-19 era].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:819-825.
    >> Share

    July 2022
  27. CAI YQ, Zeng HQ, Li YP, Li NS, et al
    [Advances in clinical prediction scores for prognosis of coronavirus disease-2019].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:706-711.
    >> Share

    June 2022
  28. LIU J, Wu JL, Liu GC, Jiang P, et al
    [Research progress on physiological changes caused by wearing N95 mask in patients with chronic obstruction pulmonary disease].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:598-602.
    >> Share

  29. XU FY, Zhai ZG
    [Annual review of venous thromboembolism in 2021].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:588-592.
    >> Share

    May 2022
  30. TENG PK, Han XD, Liu YZ, Zhao WY, et al
    [Clinical characteristics and outcome analysis of COVID-19 patients with pulmonary tuberculosis].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:510-514.
    >> Share

    April 2022

  31. [Chinese expert consensus on the use of Omalizumab in allergic asthma (2021 version)].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:341-354.
    >> Share

  32. SUN YC
    [Focus on influenza vaccination in patients with chronic obstructive pulmonary disease].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:333-334.
    >> Share

    January 2022
  33. SONG LC, Xie LX
    [Clinical update in critical care of pulmonary medicine 2021].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:83-87.
    >> Share

  34. ZHA SS, He ZF, Guan LL, Niu JY, et al
    [Clinical research progress in non-invasive positive pressure ventilation from 2020 to 2021].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:72-77.
    >> Share

  35. ZHOU M, Qu JM
    [Update on COVID-19 in 2021].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:67-71.
    >> Share

    November 2021
  36. SUN JW, Cui ZF, Li FJ, Liu MY, et al
    [Epidemiological characteristics of novel coronavirus pneumonia in Shijiazhuang, China].
    Zhonghua Jie He He Hu Xi Za Zhi. 2021;44:961-965.
    >> Share

    September 2021
  37. LONG QY, Zheng YL, Gao ZC
    [Analysis of the clinical characteristics of COVID-19 reinfection cases].
    Zhonghua Jie He He Hu Xi Za Zhi. 2021;44:793-799.
    >> Share

    August 2021
  38. SU B, Song Y, Hu K
    [Management strategies for obstructive sleep apnea under the normalized prevention and control of the novel coronavirus pneumonia epidemic].
    Zhonghua Jie He He Hu Xi Za Zhi. 2021;44:741-745.
    >> Share

    May 2021
  39. WANG L, Fan JP, Xu Y, Wang JL, et al
    [Progress and challenge of COVID-19 vaccine development].
    Zhonghua Jie He He Hu Xi Za Zhi. 2021;44:492-496.
    >> Share

  40. LIU B, Wang P, Yang DX, Xiong WN, et al
    [Development of multiple organ dysfunction syndrome in patients with Coronavirus Disease 2019: clinical characteristics and risk factors].
    Zhonghua Jie He He Hu Xi Za Zhi. 2021;44:435-442.
    >> Share

    April 2021
  41. XIAO YJ, Dong X, Yang HZ, Tan HY, et al
    [Clinical features of 141 fatal cases of coronavirus disease in Jinyintan Hospital in Wuhan, China].
    Zhonghua Jie He He Hu Xi Za Zhi. 2021;44:354-359.
    >> Share

    March 2021
  42. LI S, Liu SY, Zhao YQ, Li QY, et al
    [Spatial and temporal distribution and predictive value of chest CT scoring in patients with COVID-19].
    Zhonghua Jie He He Hu Xi Za Zhi. 2021;44:230-236.
    >> Share

    January 2021
  43. XU Y, Gao ZC
    [Interpretation of diagnosis and treatment for novel coronavirus pneumonia (Trial Eighth Edition)].
    Zhonghua Jie He He Hu Xi Za Zhi. 2021;44:11-13.
    >> Share

  44. SHEN N, Liu BB, He B
    [Co-infection in Coronavirus disease and progress in antibiotic therapy].
    Zhonghua Jie He He Hu Xi Za Zhi. 2021;44:4-7.
    >> Share

    December 2020

  45. [Antiviral therapy of COVID-19].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:1096-1099.
    >> Share

  46. SHI LY, Cai YP, Zhang YX, Lin YL, et al
    [A comparison of clinical characteristics between patients with and without"recurrence"RNA positive with COVID-19].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:1066-1070.
    >> Share

    November 2020
  47. NIE NF, He Y
    [Potential therapeutic drugs for novel coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:970-974.
    >> Share

    October 2020
  48. WANG X, Hu ZW, Hu Y, Cheng Y, et al
    [Comparison of severity classification of Chinese protocol, pneumonia severity index and CURB-65 in risk stratification and prognostic assessment of coronavirus disease 2019].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:834-838.
    >> Share


  49. [Expert recommendations for the diagnosis and treatment of interstitial lung disease caused by novel coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:827-833.
    >> Share

    September 2020

  50. [Recommendation of respiratory rehabilitation for PICS in critically ill patients with COVID-19].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:737-743.
    >> Share

  51. ZHAN X, Liu B, Tong ZH
    [Postinflammatroy pulmonary fibrosis of COVID-19: the current status and perspective].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:728-732.
    >> Share

  52. XIA JG, Li M, Zhan QY
    [Intervention timing of invasive mechanical ventilation and extracorporeal membrane oxygenation in the treatment of severe COVID-19].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:725-728.
    >> Share

  53. PAN PH, Song C, Lu RL
    [The timing of continuous renal replacement therapy in severe COVID-19].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:721-724.
    >> Share

  54. XIE LX, Xie SL
    [Immune imbalance and immunoregulatory treatment of COVID-19].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:717-721.
    >> Share

    August 2020
  55. ZHU Q, Zhang W, Wang Q, Liu JH, et al
    [Clinical characteristics and outcome of 64 patients with severe COVID-19].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:659-664.
    >> Share

  56. ZENG YL, Zhang C, Gao F, Ma L, et al
    [Analysis of clinical characteristics of 49 cases of COVID-19].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:654-658.
    >> Share

  57. QIN W, Hu BZ, Zhang Z, Chen S, et al
    [Clinical characteristics and death risk factors of severe COVID-19].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:648-653.
    >> Share

    June 2020
  58. LU XF, Gong W, Wang L, Li L, et al
    [Clinical features and high resolution CT imaging evolution of coronavirus disease 2019].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:509-515.
    >> Share


  59. [Guide for the prevention and treatment of coronavirus disease 2019].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:473-489.
    >> Share

    May 2020
  60. ZHANG SX, Li J, Zhou P, Na JR, et al
    [The analysis of clinical characteristics of 34 novel coronavirus pneumonia cases in Ningxia Hui autonomous region].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:431-436.
    >> Share


  61. [Diagnosis and Treatment Protocol for COVID-19 from Military Medical Team Supporting Wuhan (Trial Version 2)].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:414-420.
    >> Share

  62. ZHAO Q, He Y
    [Application of convalescent plasma therapy on novel coronavirus infection].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:409-413.
    >> Share

    April 2020

  63. [Expert consensus on sleep study and non-invasive positive airway pressure therapy during the epidemic of coronavirus disease 2019].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E043.
    >> Share

  64. SUN C, Zhang XB, Dai Y, Xu XZ, et al
    [Clinical analysis of 150 cases of 2019 novel coronavirus infection in Nanyang City, Henan Province].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E042.
    >> Share

  65. LIU YJ, Yang YL, Xu Y
    [What we learned from SARS may provide important insights into understanding and management of coronavirus disease 2019].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:339-344.
    >> Share

  66. TAN FR, Qiu YL, Xu Z
    [Bronchoalveolar lavage fluid was used to diagnose two cases of 2019-nCoV infection].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:337-339.
    >> Share


  67. [Recommendations for respiratory rehabilitation of coronavirus disease 2019 in adult].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:308-314.
    >> Share


  68. [Expert consensus on preventing nosocomial transmission during respiratory care for critically ill patients infected by 2019 novel coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:288-296.
    >> Share

  69. LI XY, Du B, Wang YS, Kang HYJ, et al
    [The keypoints in treatment of the critical coronavirus disease 2019 patient(2)].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:277-281.
    >> Share

  70. SHI Y
    [What are the highlights of "Diagnosis and treatment of disease 2019 novel coronavirus infection suitable for Military support Hubei medical team"].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:315-320.
    >> Share

  71. QIU HB, Li XY, Du B, Kang HYJ, et al
    [The keypoints in treatment of the critical coronavirus disease 2019 patient(1)].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:273-277.
    >> Share

  72. ZHANG T, Sun LX, Feng RE
    [Comparison of clinical and pathological features between severe acute respiratory syndrome and coronavirus disease 2019].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E040.
    >> Share

    March 2020
  73. REN YH, Wang SY, Liu M, Guo YM, et al
    [When COVID-19 encounters interstitial lung disease: challenges and management].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E039.
    >> Share

  74. LI HC, Ma J, Zhang H, Cheng Y, et al
    [Thoughts and practice on the treatment of severe and critical new coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E038.
    >> Share

  75. SUN ML, Yang JM, Sun YP, Su GH, et al
    [Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:219-222.
    >> Share

  76. ZHANG MQ, Wang XH, Chen YL, Zhao KL, et al
    [Clinical features of 2019 novel coronavirus pneumonia in the early stage from a fever clinic in Beijing].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:215-218.
    >> Share

  77. CHEN L, Liu HG, Liu W, Liu J, et al
    [Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:203-208.
    >> Share


  78. [Expert consensus for bronchoscopy during the epidemic of 2019 novel coronavirus infection (Trial version)].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:199-202.
    >> Share


  79. [Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:185-188.
    >> Share

  80. ZHAO JP, Hu Y, Du RH, Chen ZS, et al
    [Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:183-184.
    >> Share

  81. YANG F, Liu N, Hu JY, Wu LL, et al
    [Pulmonary rehabilitation guidelines in the principle of 4S for patients infected with 2019 novel coronavirus (2019-nCoV)].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:180-182.
    >> Share

  82. YUAN X, Mu JS, Mo GX, Hu XS, et al
    [Respiratory support for severe 2019-nCoV pneumonia suffering from acute respiratory failure: time and strategy].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:177-180.
    >> Share

  83. DU B, Qiu HB, Zhan X, Wang YS, et al
    [Pharmacotherapeutics for the new coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:173-176.
    >> Share

  84. LI H, Wang YM, Xu JY, Cao B, et al
    [Potential antiviral therapeutics for 2019 Novel Coronavirus].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:170-172.
    >> Share

  85. ZHOU L, Liu HG
    [Early detection and disease assessment of patients with novel coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:167-170.
    >> Share

  86. GAO ZC
    [Efficient management of novel coronavirus pneumonia by efficient prevention and control in scientific manner].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:163-166.
    >> Share


  87. [Medical management and prevention instruction of chronic obstructive pulmonary disease during the coronavirus disease 2019 epidemic].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E034.
    >> Share

  88. TIAN XL, Peng M, Wang HP, Cai BQ, et al
    [The differential diagnosis for novel coronavirus pneumonia and similar lung diseases in general hospitals].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E035.
    >> Share

  89. CAI SJ, Wu LL, Chen DF, Li YX, et al
    [Analysis of bronchoscope-guided tracheal intubation in 12 cases with COVID-19 under the personal protective equipment with positive pressure protective hood].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E033.
    >> Share


  90. [Expert consensus on Pulmonary Function Testing during the epidemic of Corona Virus Disease 2019].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E032.
    >> Share


  91. [Expert recommendations on the management of patients with advanced non-small cell lung cancer during epidemic of COVID-19 (Trial version)].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E031.
    >> Share

  92. WU J, Feng CL, Xian XY, Qiang J, et al
    [Novel coronavirus pneumonia (COVID-19) CT distribution and sign features].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E030.
    >> Share


  93. [Recommendations for respiratory rehabilitation of COVID-19 in adult].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E029.
    >> Share

  94. ZHOU L, Liu K, Liu HG
    [Cause analysis and treatment strategies of "recurrence" with novel coronavirus pneumonia (covid-19) patients after discharge from hospital].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E028.
    >> Share

  95. CHENG JL, Huang C, Zhang GJ, Liu DW, et al
    [Epidemiological characteristics of novel coronavirus pneumonia in Henan].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E027.
    >> Share

    February 2020
  96. LI XY, Du B, Wang YS, Kang HYJ, et al
    [The keypoints in treatment of the critical coronavirus disease 2019 patient].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E026.
    >> Share

  97. LI YY, Wang WN, Lei Y, Zhang B, et al
    [Comparison of the clinical characteristics between RNA positive and negative patients clinically diagnosed with 2019 novel coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E023.
    >> Share


  98. [Expert consensus on preventing nosocomial transmission during respiratory care for critically ill patients infected by 2019 novel coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;17:E020.
    >> Share


  99. [Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E019.
    >> Share

  100. SUN ML, Yang JM, Sun YP, Su GH, et al
    [Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E014.
    >> Share

  101. DU B, Qiu HB, Zhan X, Wang YS, et al
    [Pharmacotherapeutics for the New Coronavirus Pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E012.
    >> Share

  102. YUAN X, Mu JS, Mo GX, Hu XS, et al
    [Respiratory support for severe 2019-nCoV pneumonia suffering from acute respiratory failure: time and strategy].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E010.
    >> Share

  103. ZHAO JP, Hu Y, Du RH, Chen ZS, et al
    [Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E007.
    >> Share


  104. [Expert consensus for bronchoscopy during the epidemic of 2019 Novel Coronavirus infection (Trial version)].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E006.
    >> Share

  105. CHEN L, Liu HG, Liu W, Liu J, et al
    [Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E005.
    >> Share

  106. YANG F, Liu N, Wu JY, Hu LL, et al
    [Pulmonary rehabilitation guidelines in the principle of 4S for patients infected with 2019 novel coronavirus (2019-nCoV)].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E004.
    >> Share

  107. ZHOU L, Liu HG
    [Early detection and disease assessment of patients with novel coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E003.
    >> Share

  108. LI H, Wang YM, Xu JY, Cao B, et al
    [Potential antiviral therapeutics for 2019 Novel Coronavirus].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E002.
    >> Share

  109. GAO ZC
    [Efficient management of novel coronavirus pneumonia by efficient prevention and control in scientific manner].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E001.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016